Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

European clinical isolate of Proteus mirabilis harbouring the Salmonella genomic island 1 variant SGI1-O.

Doublet B, Poirel L, Praud K, Nordmann P, Cloeckaert A.

J Antimicrob Chemother. 2010 Oct;65(10):2260-2. doi: 10.1093/jac/dkq283. Epub 2010 Aug 3. No abstract available.

PMID:
20682564
2.

Proteus mirabilis clinical isolate harbouring a new variant of Salmonella genomic island 1 containing the multiple antibiotic resistance region.

Ahmed AM, Hussein AI, Shimamoto T.

J Antimicrob Chemother. 2007 Feb;59(2):184-90. Epub 2006 Nov 16.

PMID:
17114173
3.
4.

Salmonella genomic island 1 (SGI1), variant SGI1-I, and new variant SGI1-O in proteus mirabilis clinical and food isolates from China.

Boyd DA, Shi X, Hu QH, Ng LK, Doublet B, Cloeckaert A, Mulvey MR.

Antimicrob Agents Chemother. 2008 Jan;52(1):340-4. Epub 2007 Nov 19.

5.

New variant Salmonella genomic island 1-U in Proteus mirabilis clinical and food isolates from South China.

Bi S, Yan H, Chen M, Zhang Z, Shi L, Wang H.

J Antimicrob Chemother. 2011 May;66(5):1178-9. doi: 10.1093/jac/dkr030. Epub 2011 Feb 15. No abstract available.

PMID:
21393148
6.

Emergence of Salmonella genomic island 1 (SGI1) among Proteus mirabilis clinical isolates in Dijon, France.

Siebor E, Neuwirth C.

J Antimicrob Chemother. 2013 Aug;68(8):1750-6. doi: 10.1093/jac/dkt100. Epub 2013 Apr 10.

PMID:
23580563
7.

Proteus genomic island 1 (PGI1), a new resistance genomic island from two Proteus mirabilis French clinical isolates.

Siebor E, Neuwirth C.

J Antimicrob Chemother. 2014 Dec;69(12):3216-20. doi: 10.1093/jac/dku314. Epub 2014 Aug 11.

PMID:
25114166
8.

Integration of the blaNDM-1 carbapenemase gene into Proteus genomic island 1 (PGI1-PmPEL) in a Proteus mirabilis clinical isolate.

Girlich D, Dortet L, Poirel L, Nordmann P.

J Antimicrob Chemother. 2015 Jan;70(1):98-102. doi: 10.1093/jac/dku371. Epub 2014 Sep 18.

PMID:
25239462
9.

Survey of multidrug resistance integrative mobilizable elements SGI1 and PGI1 in Proteus mirabilis in humans and dogs in France, 2010-13.

Schultz E, Haenni M, Mereghetti L, Siebor E, Neuwirth C, Madec JY, Cloeckaert A, Doublet B.

J Antimicrob Chemother. 2015 Sep;70(9):2543-6. doi: 10.1093/jac/dkv154. Epub 2015 Jun 11.

PMID:
26066582
10.

Molecular characteristics of Salmonella genomic island 1 in Proteus mirabilis isolates from poultry farms in China.

Lei CW, Zhang AY, Liu BH, Wang HN, Guan ZB, Xu CW, Xia QQ, Cheng H, Zhang DD.

Antimicrob Agents Chemother. 2014 Dec;58(12):7570-2. doi: 10.1128/AAC.03992-14. Epub 2014 Sep 29.

11.

Potential integration sites of the Salmonella genomic island 1 in Proteus mirabilis and other bacteria.

Doublet B, Golding GR, Mulvey MR, Cloeckaert A.

J Antimicrob Chemother. 2007 Apr;59(4):801-3. Epub 2007 Feb 9. No abstract available.

PMID:
17293370
12.

The complete sequence of Salmonella genomic island SGI1-K.

Hamidian M, Holt KE, Hall RM.

J Antimicrob Chemother. 2015 Jan;70(1):305-6. doi: 10.1093/jac/dku331. Epub 2014 Sep 4. No abstract available.

PMID:
25193084
13.

Association of IS26-composite transposons and complex In4-type integrons generates novel multidrug resistance loci in Salmonella genomic island 1.

Doublet B, Praud K, Weill FX, Cloeckaert A.

J Antimicrob Chemother. 2009 Feb;63(2):282-9. doi: 10.1093/jac/dkn500. Epub 2008 Dec 11.

PMID:
19074421
14.

Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.

Luzzaro F, Brigante G, D'Andrea MM, Pini B, Giani T, Mantengoli E, Rossolini GM, Toniolo A.

Int J Antimicrob Agents. 2009 Apr;33(4):328-33. doi: 10.1016/j.ijantimicag.2008.09.007. Epub 2008 Dec 17.

PMID:
19095415
15.

Emergence of Extensively Drug-Resistant Proteus mirabilis Harboring a Conjugative NDM-1 Plasmid and a Novel Salmonella Genomic Island 1 Variant, SGI1-Z.

Qin S, Qi H, Zhang Q, Zhao D, Liu ZZ, Tian H, Xu L, Xu H, Zhou M, Feng X, Liu HM.

Antimicrob Agents Chemother. 2015 Oct;59(10):6601-4. doi: 10.1128/AAC.00292-15. Epub 2015 Jul 20.

16.

Two novel Salmonella genomic island 1 variants in Proteus mirabilis isolates from swine farms in China.

Lei CW, Zhang AY, Liu BH, Wang HN, Yang LQ, Guan ZB, Xu CW, Zhang DD, Yang YQ.

Antimicrob Agents Chemother. 2015 Jul;59(7):4336-8. doi: 10.1128/AAC.00120-15. Epub 2015 Apr 27.

17.

Prevalence and resistance patterns of extended-spectrum and AmpC β-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital.

Park SD, Uh Y, Lee G, Lim K, Kim JB, Jeong SH.

APMIS. 2010 Oct;118(10):801-8. doi: 10.1111/j.1600-0463.2010.02663.x. Epub 2010 Aug 17.

PMID:
20854475
18.

Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.

Saito R, Sato K, Kumita W, Inami N, Nishiyama H, Okamura N, Moriya K, Koike K.

J Antimicrob Chemother. 2006 Sep;58(3):673-7. Epub 2006 Jul 26.

PMID:
16870650
19.

A novel functional class 2 integron in clinical Proteus mirabilis isolates.

Wei Q, Hu Q, Li S, Lu H, Chen G, Shen B, Zhang P, Zhou Y.

J Antimicrob Chemother. 2014 Apr;69(4):973-6. doi: 10.1093/jac/dkt456. Epub 2013 Nov 13.

PMID:
24235093
20.

Mobilization of the Salmonella genomic island SGI1 and the Proteus genomic island PGI1 by the A/C2 plasmid carrying blaTEM-24 harboured by various clinical species of Enterobacteriaceae.

Siebor E, de Curraize C, Amoureux L, Neuwirth C.

J Antimicrob Chemother. 2016 Aug;71(8):2167-70. doi: 10.1093/jac/dkw151. Epub 2016 May 5.

PMID:
27150396

Supplemental Content

Support Center